LONDON -GSK raised its full-year profit and sales guidance on Wednesday after its second-quarter earnings beat expectations, helped by strong sales of its shingles vaccine Shingrix and HIV medicines. The strong results may further help revive investor confidence in CEO Emma Walmsley, coming a year after the company spun off its consumer health business, Haleon, in its most radical shake-up in 20 years. Walmsley, at the helm since 2017, said in a media call investors would come to better appreciate the progress made in drug and vaccine development.
LiuGong Enters Second Half of 2023 with Continued Momentum, Strong Sales, Enhanced Team and Electric Energy tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Strong Sales and Adjusted EBITDA
Reaffirming Fiscal 2024 Full Year Guidance
FORT WORTH, Texas, July7, 2023 /PRNewswire/ AZZ Inc. , the leading independent provider of hot-dip galvanizing.